Full Text
HTA114 Characterizing Oncology Outcomes in Canada's Drug Agency (CDA-AMC) Reviews From 2022 -2023

Abstract

Authors

K Mann C Hnatiuk C Malmberg

Back to Volume 27, Supplemental Issue 12S
Your browser is out-of-date

ISPOR recommends that you update your browser for more security, speed and the best experience on ispor.org. Update my browser now

×